The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of neoadjuvant gemcitabine/nab-paclitaxel and SBRT for potentially resectable pancreas cancer: An evaluation of acute toxicity.
 
Manisha Palta
Employment - Duke University
Honoraria - Oakstone Publishing
Consulting or Advisory Role - Navigant Consulting
Research Funding - Merck (Inst)
Other Relationship - UpToDate
 
Brian G. Czito
Consulting or Advisory Role - Merrimack
Research Funding - Abbvie/Genentech
Patents, Royalties, Other Intellectual Property - UpToDate
 
Eileen Duffy
No Relationships to Disclose
 
Mary Malicki
No Relationships to Disclose
 
Donna Niedzwiecki
No Relationships to Disclose
 
James L. Abbruzzese
Honoraria - AstraZeneca; Celgene; Fujifilm; Halozyme; Sun Pharma
Consulting or Advisory Role - Bessor Pharma; Celgene; EMD Serono; Fujifilm; Halozyme; Sun Biopharma
 
Hope Elizabeth Uronis
Employment - GeneCentric (I)
Stock and Other Ownership Interests - GeneCentric (I)
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Advaxis (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lycera (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Gerard C. Blobe
No Relationships to Disclose
 
Dan G. Blazer
No Relationships to Disclose
 
Christopher Willett
Consulting or Advisory Role - Entrinsic Health